Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 16, 2026
Morgan Stanley (MS) Reports Record Q2 Revenues and EPS Amid Strong Asset Growth

Morgan Stanley (MS) Reports Record Q2 Revenues and EPS Amid Strong Asset Growth

Key Takeaways

  • Morgan Stanley reported record net revenues of $21.3 billion for the second quarter ended June 30, 2026.
  • Diluted earnings per share reached $3.46, up from $2.13 in the same quarter a year earlier.
  • Net income applicable to Morgan Stanley totaled $5.6 billion.
  • Return on tangible common equity (ROTCE) stood at 26.6%.
  • Wealth Management added a record $148 billion in net new assets, pushing total client assets to the $10 trillion milestone.
  • Institutional Securities delivered record revenues of $11 billion, driven by equities and investment banking momentum.

Earnings Context and Why It Matters

Morgan Stanley’s second quarter results reflect the strength of its integrated business model amid favorable market conditions. The firm’s performance builds on prior quarters, with continued growth in equities trading, investment banking activity, and wealth management inflows. For investors, these figures provide insight into how the company is navigating a dynamic environment of client engagement, capital accretion, and operational efficiency across its Institutional Securities, Wealth Management, and Investment Management segments. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Reported Results

Morgan Stanley reported net revenues of $21.3 billion for the second quarter of 2026, compared with $16.8 billion a year earlier. Net income applicable to the firm reached $5.6 billion, or $3.46 per diluted share, versus $3.5 billion, or $2.13 per diluted share, in the prior-year period. The company achieved a return on tangible common equity (ROTCE) of 26.6%. Pre-tax income totaled $7.3 billion. These results exceeded consensus estimates, with EPS surpassing analyst projections of approximately $2.89 to $2.94. Wealth Management contributed significantly with record net new assets of $148 billion, while total client assets across Wealth and Investment Management reached $10 trillion. Institutional Securities posted record segment revenues of $11 billion.

Market Reaction and Investor Sentiment

Following the July 15, 2026 release, investor attention centered on the record top-line and bottom-line figures. The strong beat on earnings and revenue, combined with robust asset growth in Wealth Management, supported positive sentiment. Market participants noted the firm’s ability to deliver operating leverage through disciplined execution despite ongoing strategic investments. From what I see, the integrated model continues to provide a meaningful edge in capturing both institutional and retail flows.

Using AI Tools for Deeper Analysis

When evaluating earnings like these, I often turn to Tickeron’s AI tools to scan for comparable patterns across the financial sector. One resource that stands out is the AI Screener, an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. In my view, this kind of capability adds useful context when reviewing results from a firm like Morgan Stanley (MS).

Forward Outlook and Key Factors to Monitor

Investors will watch how the firm sustains momentum from its record first-half performance into the second half of the year. Key areas include continued client engagement in equities and investment banking, as well as the pace of net new asset inflows in Wealth Management. Management highlighted the benefits of the integrated firm model, which connects institutional and retail clients globally.

Cost discipline remains important, with technology-driven spending supporting infrastructure, AI-enabled efficiencies, and business growth. The year-to-date efficiency ratio of 65% provides a baseline for monitoring operating leverage.

Broader industry dynamics, such as market volatility, interest rate trends, and capital markets activity, will influence results. Capital accretion continues to offer flexibility for investments and shareholder returns. Upcoming catalysts include third-quarter developments and any updates on strategic initiatives across the firm’s segments. I’m watching this closely to see how the momentum carries forward.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MS

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


MS's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for MS turned positive on August 06, 2026. Looking at past instances where MS's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 07, 2026. You may want to consider a long position or call options on MS as a result. In of 71 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

MS moved above its 50-day moving average on August 12, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MS advanced for three days, in of 357 cases, the price rose further within the following month. The odds of a continued upward trend are .

MS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 295 cases where MS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 10-day moving average for MS crossed bearishly below the 50-day moving average on July 30, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.221) is normal, around the industry mean (4.288). P/E Ratio (17.640) is within average values for comparable stocks, (21.728). Projected Growth (PEG Ratio) (2.069) is also within normal values, averaging (1.677). Dividend Yield (0.019) settles around the average of (0.033) among similar stocks. P/S Ratio (4.724) is also within normal values, averaging (31.480).

Notable companies

The most notable companies in this group are Morgan Stanley (NYSE:MS), Goldman Sachs Group (NYSE:GS), Charles Schwab Corp (The) (NYSE:SCHW), Gold.com Inc. (NYSE:GOLD).

Industry description

These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.

Market Cap

The average market capitalization across the Investment Banks/Brokers Industry is 13.15B. The market cap for tickers in the group ranges from 13 to 928.5B. PKRSF holds the highest valuation in this group at 928.5B. The lowest valued company is BFCH at 13.

High and low price notable news

The average weekly price growth across all stocks in the Investment Banks/Brokers Industry was 2%. For the same Industry, the average monthly price growth was -0%, and the average quarterly price growth was -10%. CANG experienced the highest price growth at 42%, while NCPL experienced the biggest fall at -22%.

Volume

The average weekly volume growth across all stocks in the Investment Banks/Brokers Industry was 3%. For the same stocks of the Industry, the average monthly volume growth was 1% and the average quarterly volume growth was -53%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 64
P/E Growth Rating: 70
Price Growth Rating: 63
SMR Rating: 76
Profit Risk Rating: 85
Seasonality Score: -8 (-100 ... +100)
View a ticker or compare two or three
MS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of diversified financial services including brokerage, investment management and venture capital services

Industry InvestmentBanksBrokers

Profile
Details
Industry
Investment Banks Or Brokers
Address
1585 Broadway
Phone
+1 212 761-4000
Employees
80000
Web
https://www.morganstanley.com
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.